Skip to main navigation Skip to search Skip to main content

AB203. SOH25_AB_324. Systematic review of orally available selective estrogen receptor degraders (SERDS) in treatment of estrogen receptor positive (ER+) breast cancer

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
JournalMesentery and Peritoneum
Volume9
Issue number0
Publication statusPublished - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this